Cargando…
In vivo administration of interleukin 2 plus T cell-depleted syngeneic marrow prevents graft-versus-host disease mortality and permits alloengraftment
Previous work from this laboratory has demonstrated that T cell- depleted (TCD) syngeneic marrow can delay, but not prevent, the mortality from acute graft-vs.-host disease (GVHD) caused by MHC- mismatched lymphoid cells administered to lethally irradiated mice. We demonstrate here that a protective...
| Formato: | Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
The Rockefeller University Press
1990
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2187782/ https://www.ncbi.nlm.nih.gov/pubmed/2307931 |